Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis

R. D. Wilson, J. M. Johnson, J. Dansereau, J. Singer, S. L. Drinnan, E. J T Winsor, S. Soanes, D. Kalousek, J. Hillier, M. F. Ho, J. Brown, P. Wyatt, S. Farrell, J. O'Farrell, D. Chadwick, R. Natale, C. Mitchell, Yao-Shan Fan, P. Mohide, M. L. BeecroftD. J. Tomkins, R. Carter, R. Benzie, B. MacLean, H. S. Wang, L. Dallaire, M. DesRochers, F. Tihy, P. Eydoux, S. Provencher, L. Cartier, B. A. Armson, H. Hogg, J. P. Welch, C. Harman, K. Babaian, A. Dawson, N. Okun, M. Park, J. C C Lin, G. Robinson, A. Summers

Research output: Contribution to journalArticle

220 Citations (Scopus)

Abstract

Background. Most published reports on early amniocentesis are of cohort studies rather than randomised trials. This study was designed to assess the safety and cytogenetic accuracy of early amniocentesis in contrast to midtrimester amniocentesis in a randomised multicentre setting. Methods. Pregnant women were randomly allocated early amniocentesis (between 11+0 and 12+6 gestational weeks(days)) or midtrimester (between 15+0 and 16+6 gestational weeks(days)) amniocentesis. A detailed fetal ultrasound examination was done between 15 and 20 gestational weeks in all women. All amniocenteses were done under continuous ultrasound guidance: 11 mL (early amniocentesis) or 20 mL (midtrimester amniocentesis) of amniotic fluid were removed for cytogenic analysis. No more than two needle insertions were done on the same day. All fetal losses (spontaneous or induced abortions) were counted as outcome events and post-procedural losses had cytogenic analysis. Maternal and fetal health were assessed at 20-22 weeks and 5 weeks after delivery. Logistic regression analysis was used to assess the significance of the differences between the early amniocentesis and midtrimester amniocentesis groups. Findings. 4374 pregnant women took part in the study. 1916 (87.8%) of 2183 women in the early amniocentesis group had their amniocentesis before 13 gestational weeks. 1775 (81.2%) of 2185 women in the midtrimester group had their amniocentesis after 15 gestational weeks. There was a significant difference in total fetal losses for early amniocentesis compared with midtrimester amniocentesis (7.6% vs 5.9%; difference 1.7%, one-sided CI 2.98%, p = 0.012). There was a significant increase in talipes equinovarus in the early amniocentesis group compared with the midtrimester amniocentesis group (1.3% vs 0.1%, p = 0.0001). There was a significant difference in postprocedural amniotic-fluid leakage (early amniocentesis 3.5% vs midtrimester amniocentesis 1.7%, p = 0.0007). Interpretation. Our study shows that early amniocentesis is associated with an increased risk of fetal loss and talipes equinovarus. Our results should be taken into consideration when invasive prenatal diagnosis is being offered.

Original languageEnglish (US)
Pages (from-to)242-247
Number of pages6
JournalLancet
Volume351
Issue number9098
DOIs
StatePublished - Jan 24 1998
Externally publishedYes

Fingerprint

Amniocentesis
Second Pregnancy Trimester
Safety
Clubfoot
Amniotic Fluid
Pregnant Women

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Wilson, R. D., Johnson, J. M., Dansereau, J., Singer, J., Drinnan, S. L., Winsor, E. J. T., ... Summers, A. (1998). Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. Lancet, 351(9098), 242-247. https://doi.org/10.1016/S0140-6736(97)12346-7

Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. / Wilson, R. D.; Johnson, J. M.; Dansereau, J.; Singer, J.; Drinnan, S. L.; Winsor, E. J T; Soanes, S.; Kalousek, D.; Hillier, J.; Ho, M. F.; Brown, J.; Wyatt, P.; Farrell, S.; O'Farrell, J.; Chadwick, D.; Natale, R.; Mitchell, C.; Fan, Yao-Shan; Mohide, P.; Beecroft, M. L.; Tomkins, D. J.; Carter, R.; Benzie, R.; MacLean, B.; Wang, H. S.; Dallaire, L.; DesRochers, M.; Tihy, F.; Eydoux, P.; Provencher, S.; Cartier, L.; Armson, B. A.; Hogg, H.; Welch, J. P.; Harman, C.; Babaian, K.; Dawson, A.; Okun, N.; Park, M.; Lin, J. C C; Robinson, G.; Summers, A.

In: Lancet, Vol. 351, No. 9098, 24.01.1998, p. 242-247.

Research output: Contribution to journalArticle

Wilson, RD, Johnson, JM, Dansereau, J, Singer, J, Drinnan, SL, Winsor, EJT, Soanes, S, Kalousek, D, Hillier, J, Ho, MF, Brown, J, Wyatt, P, Farrell, S, O'Farrell, J, Chadwick, D, Natale, R, Mitchell, C, Fan, Y-S, Mohide, P, Beecroft, ML, Tomkins, DJ, Carter, R, Benzie, R, MacLean, B, Wang, HS, Dallaire, L, DesRochers, M, Tihy, F, Eydoux, P, Provencher, S, Cartier, L, Armson, BA, Hogg, H, Welch, JP, Harman, C, Babaian, K, Dawson, A, Okun, N, Park, M, Lin, JCC, Robinson, G & Summers, A 1998, 'Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis', Lancet, vol. 351, no. 9098, pp. 242-247. https://doi.org/10.1016/S0140-6736(97)12346-7
Wilson RD, Johnson JM, Dansereau J, Singer J, Drinnan SL, Winsor EJT et al. Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. Lancet. 1998 Jan 24;351(9098):242-247. https://doi.org/10.1016/S0140-6736(97)12346-7
Wilson, R. D. ; Johnson, J. M. ; Dansereau, J. ; Singer, J. ; Drinnan, S. L. ; Winsor, E. J T ; Soanes, S. ; Kalousek, D. ; Hillier, J. ; Ho, M. F. ; Brown, J. ; Wyatt, P. ; Farrell, S. ; O'Farrell, J. ; Chadwick, D. ; Natale, R. ; Mitchell, C. ; Fan, Yao-Shan ; Mohide, P. ; Beecroft, M. L. ; Tomkins, D. J. ; Carter, R. ; Benzie, R. ; MacLean, B. ; Wang, H. S. ; Dallaire, L. ; DesRochers, M. ; Tihy, F. ; Eydoux, P. ; Provencher, S. ; Cartier, L. ; Armson, B. A. ; Hogg, H. ; Welch, J. P. ; Harman, C. ; Babaian, K. ; Dawson, A. ; Okun, N. ; Park, M. ; Lin, J. C C ; Robinson, G. ; Summers, A. / Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. In: Lancet. 1998 ; Vol. 351, No. 9098. pp. 242-247.
@article{c146b89a8fe14318aea1feb3106a82bb,
title = "Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis",
abstract = "Background. Most published reports on early amniocentesis are of cohort studies rather than randomised trials. This study was designed to assess the safety and cytogenetic accuracy of early amniocentesis in contrast to midtrimester amniocentesis in a randomised multicentre setting. Methods. Pregnant women were randomly allocated early amniocentesis (between 11+0 and 12+6 gestational weeks(days)) or midtrimester (between 15+0 and 16+6 gestational weeks(days)) amniocentesis. A detailed fetal ultrasound examination was done between 15 and 20 gestational weeks in all women. All amniocenteses were done under continuous ultrasound guidance: 11 mL (early amniocentesis) or 20 mL (midtrimester amniocentesis) of amniotic fluid were removed for cytogenic analysis. No more than two needle insertions were done on the same day. All fetal losses (spontaneous or induced abortions) were counted as outcome events and post-procedural losses had cytogenic analysis. Maternal and fetal health were assessed at 20-22 weeks and 5 weeks after delivery. Logistic regression analysis was used to assess the significance of the differences between the early amniocentesis and midtrimester amniocentesis groups. Findings. 4374 pregnant women took part in the study. 1916 (87.8{\%}) of 2183 women in the early amniocentesis group had their amniocentesis before 13 gestational weeks. 1775 (81.2{\%}) of 2185 women in the midtrimester group had their amniocentesis after 15 gestational weeks. There was a significant difference in total fetal losses for early amniocentesis compared with midtrimester amniocentesis (7.6{\%} vs 5.9{\%}; difference 1.7{\%}, one-sided CI 2.98{\%}, p = 0.012). There was a significant increase in talipes equinovarus in the early amniocentesis group compared with the midtrimester amniocentesis group (1.3{\%} vs 0.1{\%}, p = 0.0001). There was a significant difference in postprocedural amniotic-fluid leakage (early amniocentesis 3.5{\%} vs midtrimester amniocentesis 1.7{\%}, p = 0.0007). Interpretation. Our study shows that early amniocentesis is associated with an increased risk of fetal loss and talipes equinovarus. Our results should be taken into consideration when invasive prenatal diagnosis is being offered.",
author = "Wilson, {R. D.} and Johnson, {J. M.} and J. Dansereau and J. Singer and Drinnan, {S. L.} and Winsor, {E. J T} and S. Soanes and D. Kalousek and J. Hillier and Ho, {M. F.} and J. Brown and P. Wyatt and S. Farrell and J. O'Farrell and D. Chadwick and R. Natale and C. Mitchell and Yao-Shan Fan and P. Mohide and Beecroft, {M. L.} and Tomkins, {D. J.} and R. Carter and R. Benzie and B. MacLean and Wang, {H. S.} and L. Dallaire and M. DesRochers and F. Tihy and P. Eydoux and S. Provencher and L. Cartier and Armson, {B. A.} and H. Hogg and Welch, {J. P.} and C. Harman and K. Babaian and A. Dawson and N. Okun and M. Park and Lin, {J. C C} and G. Robinson and A. Summers",
year = "1998",
month = "1",
day = "24",
doi = "10.1016/S0140-6736(97)12346-7",
language = "English (US)",
volume = "351",
pages = "242--247",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9098",

}

TY - JOUR

T1 - Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis

AU - Wilson, R. D.

AU - Johnson, J. M.

AU - Dansereau, J.

AU - Singer, J.

AU - Drinnan, S. L.

AU - Winsor, E. J T

AU - Soanes, S.

AU - Kalousek, D.

AU - Hillier, J.

AU - Ho, M. F.

AU - Brown, J.

AU - Wyatt, P.

AU - Farrell, S.

AU - O'Farrell, J.

AU - Chadwick, D.

AU - Natale, R.

AU - Mitchell, C.

AU - Fan, Yao-Shan

AU - Mohide, P.

AU - Beecroft, M. L.

AU - Tomkins, D. J.

AU - Carter, R.

AU - Benzie, R.

AU - MacLean, B.

AU - Wang, H. S.

AU - Dallaire, L.

AU - DesRochers, M.

AU - Tihy, F.

AU - Eydoux, P.

AU - Provencher, S.

AU - Cartier, L.

AU - Armson, B. A.

AU - Hogg, H.

AU - Welch, J. P.

AU - Harman, C.

AU - Babaian, K.

AU - Dawson, A.

AU - Okun, N.

AU - Park, M.

AU - Lin, J. C C

AU - Robinson, G.

AU - Summers, A.

PY - 1998/1/24

Y1 - 1998/1/24

N2 - Background. Most published reports on early amniocentesis are of cohort studies rather than randomised trials. This study was designed to assess the safety and cytogenetic accuracy of early amniocentesis in contrast to midtrimester amniocentesis in a randomised multicentre setting. Methods. Pregnant women were randomly allocated early amniocentesis (between 11+0 and 12+6 gestational weeks(days)) or midtrimester (between 15+0 and 16+6 gestational weeks(days)) amniocentesis. A detailed fetal ultrasound examination was done between 15 and 20 gestational weeks in all women. All amniocenteses were done under continuous ultrasound guidance: 11 mL (early amniocentesis) or 20 mL (midtrimester amniocentesis) of amniotic fluid were removed for cytogenic analysis. No more than two needle insertions were done on the same day. All fetal losses (spontaneous or induced abortions) were counted as outcome events and post-procedural losses had cytogenic analysis. Maternal and fetal health were assessed at 20-22 weeks and 5 weeks after delivery. Logistic regression analysis was used to assess the significance of the differences between the early amniocentesis and midtrimester amniocentesis groups. Findings. 4374 pregnant women took part in the study. 1916 (87.8%) of 2183 women in the early amniocentesis group had their amniocentesis before 13 gestational weeks. 1775 (81.2%) of 2185 women in the midtrimester group had their amniocentesis after 15 gestational weeks. There was a significant difference in total fetal losses for early amniocentesis compared with midtrimester amniocentesis (7.6% vs 5.9%; difference 1.7%, one-sided CI 2.98%, p = 0.012). There was a significant increase in talipes equinovarus in the early amniocentesis group compared with the midtrimester amniocentesis group (1.3% vs 0.1%, p = 0.0001). There was a significant difference in postprocedural amniotic-fluid leakage (early amniocentesis 3.5% vs midtrimester amniocentesis 1.7%, p = 0.0007). Interpretation. Our study shows that early amniocentesis is associated with an increased risk of fetal loss and talipes equinovarus. Our results should be taken into consideration when invasive prenatal diagnosis is being offered.

AB - Background. Most published reports on early amniocentesis are of cohort studies rather than randomised trials. This study was designed to assess the safety and cytogenetic accuracy of early amniocentesis in contrast to midtrimester amniocentesis in a randomised multicentre setting. Methods. Pregnant women were randomly allocated early amniocentesis (between 11+0 and 12+6 gestational weeks(days)) or midtrimester (between 15+0 and 16+6 gestational weeks(days)) amniocentesis. A detailed fetal ultrasound examination was done between 15 and 20 gestational weeks in all women. All amniocenteses were done under continuous ultrasound guidance: 11 mL (early amniocentesis) or 20 mL (midtrimester amniocentesis) of amniotic fluid were removed for cytogenic analysis. No more than two needle insertions were done on the same day. All fetal losses (spontaneous or induced abortions) were counted as outcome events and post-procedural losses had cytogenic analysis. Maternal and fetal health were assessed at 20-22 weeks and 5 weeks after delivery. Logistic regression analysis was used to assess the significance of the differences between the early amniocentesis and midtrimester amniocentesis groups. Findings. 4374 pregnant women took part in the study. 1916 (87.8%) of 2183 women in the early amniocentesis group had their amniocentesis before 13 gestational weeks. 1775 (81.2%) of 2185 women in the midtrimester group had their amniocentesis after 15 gestational weeks. There was a significant difference in total fetal losses for early amniocentesis compared with midtrimester amniocentesis (7.6% vs 5.9%; difference 1.7%, one-sided CI 2.98%, p = 0.012). There was a significant increase in talipes equinovarus in the early amniocentesis group compared with the midtrimester amniocentesis group (1.3% vs 0.1%, p = 0.0001). There was a significant difference in postprocedural amniotic-fluid leakage (early amniocentesis 3.5% vs midtrimester amniocentesis 1.7%, p = 0.0007). Interpretation. Our study shows that early amniocentesis is associated with an increased risk of fetal loss and talipes equinovarus. Our results should be taken into consideration when invasive prenatal diagnosis is being offered.

UR - http://www.scopus.com/inward/record.url?scp=0032562014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032562014&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(97)12346-7

DO - 10.1016/S0140-6736(97)12346-7

M3 - Article

C2 - 9457093

AN - SCOPUS:0032562014

VL - 351

SP - 242

EP - 247

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9098

ER -